Identification of salivary metabolomic biomarkers for oral cancer screening

Citations Over TimeTop 10% of 2016 papers

Abstract

The objective of this study was to explore salivary metabolite biomarkers by profiling both saliva and tumor tissue samples for oral cancer screening. Paired tumor and control tissues were obtained from oral cancer patients and whole unstimulated saliva samples were collected from patients and healthy controls. The comprehensive metabolomic analysis for profiling hydrophilic metabolites was conducted using capillary electrophoresis time-of-flight mass spectrometry. In total, 85 and 45 metabolites showed significant differences between tumor and matched control samples, and between salivary samples from oral cancer and controls, respectively (P < 0.05 correlated by false discovery rate); 17 metabolites showed consistent differences in both saliva and tissue-based comparisons. Of these, a combination of only two biomarkers yielded a high area under receiver operating characteristic curves (0.827; 95% confidence interval, 0.726-0.928, P < 0.0001) for discriminating oral cancers from controls. Various validation tests confirmed its high generalization ability. The demonstrated approach, integrating both saliva and tumor tissue metabolomics, helps eliminate pseudo-molecules that are coincidentally different between oral cancers and controls. These combined salivary metabolites could be the basis of a clinically feasible method of non-invasive oral cancer screening.

Related Papers

• → Comparison of Saliva and Midturbinate Swabs for Detection of SARS-CoV-2(2022)41 cited
• → The impact of saliva collection methods on measured salivary biomarker levels(2023)35 cited
• → Comparison of Saliva and Mid-Turbinate Swabs for Detection of COVID-19(2021)12 cited
• → Metabolism of the neuroleptic agent zetidoline in the rat and the dog.(1984)4 cited